SCWorx Corp. (WORX)

NASDAQ: WORX · IEX Real-Time Price · USD
0.440
0.00 (0.05%)
At close: Feb 7, 2023, 4:00 PM
0.462
+0.022 (5.00%)
After-hours: Feb 7, 2023, 5:51 PM EST

Company Description

SCWorx Corp. develops and markets health care information technology solutions and related services to improve healthcare processes and information flow within hospitals and other healthcare facilities in the United States.

The company provides data content and services related to repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry.

It also offers virtualized item master file repair, expansion and automation; EMR management; CDM management; contract management; request for proposal automation; rebate management; integration of acquired management; big data analytics modeling; data integration and warehousing; and ScanWorx.

In addition, the company operates an online event ticketing platform focused on serving regional mixed martial arts.

In addition, it offers CageTix, a ticketing platform for mixed martial arts industry. Further, the company focuses on selling personal protective equipment and COVID-19 rapid test kits.

It sells its solutions and services to hospitals and health systems through its direct sales force, and distribution and reseller partnerships.

SCWorx Corp. is based in New York, New York.

SCWorx Corp.
SCWorx logo
Country United States
Industry Health Information Services
Sector Healthcare
Employees 10
CEO Mr. Timothy Andrew Hannibal

Contact Details

Address:
590 Madison Avenue
New York, New York 10022
United States
Phone (212) 739-7825
Website scworx.com

Stock Details

Ticker Symbol WORX
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001674227
CUSIP Number 78396V109
ISIN Number US78396V1098
Employer ID 47-5412331
SIC Code 7990

Key Executives

Name Position
Timothy Andrew Hannibal President, Chief Executive Officer and Director
Christopher J. Kohler Chief Financial Officer

Latest SEC Filings

Date Type Title
Dec 28, 2022 8-K Current Report
Dec 9, 2022 8-K Current Report
Nov 14, 2022 10-Q Quarterly Report
Nov 7, 2022 DEF 14A Other definitive proxy statements
Nov 1, 2022 PRE 14A Other preliminary proxy statements
Oct 25, 2022 SC 13G Statement of acquisition of beneficial ownership by individuals
Sep 6, 2022 8-K Current Report
Aug 15, 2022 10-Q Quarterly Report
Aug 8, 2022 424B3 Prospectus
Aug 5, 2022 EFFECT Notice of Effectiveness